Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy and MSI status]

Gaëtan des Guetz1, Pierre-Olivier Schischmanoff

  • 1Service d'Oncologie médicale, Hôpital Avicenne, 125 rue de Stalingrad, 93 009 Bobigny. gaetan.des-guetz@avc.ap-hop-paris.fr

Gastroenterologie Clinique Et Biologique
|January 27, 2006
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-Analysis.

JTO clinical and research reports·2026
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2025
Same author

A Life course approach to investigate breast cancer and migration in the greater Paris area: the SENOVIE study protocol.

BMJ open·2025
Same author

Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacy.

Cancer immunology, immunotherapy : CII·2025
Same author

First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced <i>EGFR</i>-mutated NSCLC: a meta-analysis of randomized phase III trials.

Expert review of anticancer therapy·2024
Same author

Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.

International journal of cancer·2023